The prognostic significance of histologic variant on survival outcomes in patients with metastatic urothelial carcinoma receiving immune checkpoint inhibitor therapy

BACKGROUND: While the treatment guidelines have been established for pure urothelial carcinoma (pUC), patients with variant type urothelial carcinoma (vUC) face limited effective treatment options. The effectiveness of immune checkpoint inhibitors (ICI) in patients with vUC remains uncertain and nec...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Tsung-Han, Su, Po-Jung, Huang, Shih-Yu, Kuo, Ming-Chun, Lin, Chang-Ting, Wu, Chia-Che, Luo, Hao-Lun, Chen, Chien-Hsu, Chou, Chih-Chi, Liu, Ting-Ting, Huang, Chun-Chieh, Tsai, Kai-Lung, Su, Yu-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504763/
https://www.ncbi.nlm.nih.gov/pubmed/37715113
http://dx.doi.org/10.1186/s12885-023-11398-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504763/
https://www.ncbi.nlm.nih.gov/pubmed/37715113
http://dx.doi.org/10.1186/s12885-023-11398-w

Ejemplares similares